Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
The use of birth defect registries for etiological research: a review.

Community genetics

Reefhuis J, de Jong-van den Berg LT, Cornel MC.
PMID: 14960897
Community Genet. 2002;5(1):13-32. doi: 10.1159/000064628.

BACKGROUND: Birth defect registries are often used for etiological research. Either as hypotheses-generating studies, or studies directed at one specific association between a risk factor and a birth defect in order to confirm or refute possible associations.METHODS: A literature...

Cite
Reefhuis J, de Jong-van den Berg LT, Cornel MC. The use of birth defect registries for etiological research: a review. Community Genet. 2002;5(1):13-32doi: 10.1159/000064628.
Reefhuis, J., de Jong-van den Berg, L. T., & Cornel, M. C. (2002). The use of birth defect registries for etiological research: a review. Community genetics, 5(1), 13-32. https://doi.org/10.1159/000064628
Reefhuis, Jennita, et al. "The use of birth defect registries for etiological research: a review." Community genetics vol. 5,1 (2002): 13-32. doi: https://doi.org/10.1159/000064628
Reefhuis J, de Jong-van den Berg LT, Cornel MC. The use of birth defect registries for etiological research: a review. Community Genet. 2002;5(1):13-32. doi: 10.1159/000064628. PMID: 14960897.
Copy Download .nbib Format: NLM
Pharmacoepidemiological studies in pregnancy: the need for international collaboration.

The International journal of risk & safety in medicine

Sørensen HT, de Jong-van den Berg L.
PMID: 23511372
Int J Risk Saf Med. 1997;10(3):193-5. doi: 10.3233/JRS-1997-10306.

No abstract available.

Cite
Sørensen HT, de Jong-van den Berg L. Pharmacoepidemiological studies in pregnancy: the need for international collaboration. Int J Risk Saf Med. 1997;10(3):193-5doi: 10.3233/JRS-1997-10306.
Sørensen, H. T., & de Jong-van den Berg, L. (1997). Pharmacoepidemiological studies in pregnancy: the need for international collaboration. The International journal of risk & safety in medicine, 10(3), 193-5. https://doi.org/10.3233/JRS-1997-10306
Sørensen, H T, and de Jong-van den Berg, L. "Pharmacoepidemiological studies in pregnancy: the need for international collaboration." The International journal of risk & safety in medicine vol. 10,3 (1997): 193-5. doi: https://doi.org/10.3233/JRS-1997-10306
Sørensen HT, de Jong-van den Berg L. Pharmacoepidemiological studies in pregnancy: the need for international collaboration. Int J Risk Saf Med. 1997;10(3):193-5. doi: 10.3233/JRS-1997-10306. PMID: 23511372.
Copy Download .nbib Format: NLM
Women's opinions on the use of folic acid.

The International journal of risk & safety in medicine

Klok ER, Tijmstra T, Cornel MC, de Walle HE, de Jong-van den Berg LT.
PMID: 23511797
Int J Risk Saf Med. 1995;7(3):211-8. doi: 10.3233/JRS-1995-7306.

All women in The Netherlands who are planning a pregnancy were recently advised to take 0.5 mg of folic acid per day for 4 weeks prior to conception and during the first 8 weeks of pregnancy. In this study...

Cite
Klok ER, Tijmstra T, Cornel MC, et al. Women's opinions on the use of folic acid. Int J Risk Saf Med. 1995;7(3):211-8doi: 10.3233/JRS-1995-7306.
Klok, E. R., Tijmstra, T., Cornel, M. C., de Walle, H. E., & de Jong-van den Berg, L. T. (1995). Women's opinions on the use of folic acid. The International journal of risk & safety in medicine, 7(3), 211-8. https://doi.org/10.3233/JRS-1995-7306
Klok, E R, et al. "Women's opinions on the use of folic acid." The International journal of risk & safety in medicine vol. 7,3 (1995): 211-8. doi: https://doi.org/10.3233/JRS-1995-7306
Klok ER, Tijmstra T, Cornel MC, de Walle HE, de Jong-van den Berg LT. Women's opinions on the use of folic acid. Int J Risk Saf Med. 1995;7(3):211-8. doi: 10.3233/JRS-1995-7306. PMID: 23511797.
Copy Download .nbib Format: NLM
A study of drug utilization in pregnancy in the light of known risks: is there room for improvement?.

The International journal of risk & safety in medicine

de Jong-van den Berg LT, van den Berg PB, Peters PW, Haaijer-Ruskamp FM.
PMID: 23511586
Int J Risk Saf Med. 1990;1(2):91-105. doi: 10.3233/JRS-1990-1201.

The prescription records of 1948 Dutch women who delivered a live-born infant during an 18 month period in 1987 and 1988 were set against the Australian classification of drugs with respect to the known or suspected risks in pregnancy....

Cite
de Jong-van den Berg LT, van den Berg PB, Peters PW, et al. A study of drug utilization in pregnancy in the light of known risks: is there room for improvement?. Int J Risk Saf Med. 1990;1(2):91-105doi: 10.3233/JRS-1990-1201.
de Jong-van den Berg, L. T., van den Berg, P. B., Peters, P. W., & Haaijer-Ruskamp, F. M. (1990). A study of drug utilization in pregnancy in the light of known risks: is there room for improvement?. The International journal of risk & safety in medicine, 1(2), 91-105. https://doi.org/10.3233/JRS-1990-1201
de Jong-van den Berg, L T, et al. "A study of drug utilization in pregnancy in the light of known risks: is there room for improvement?." The International journal of risk & safety in medicine vol. 1,2 (1990): 91-105. doi: https://doi.org/10.3233/JRS-1990-1201
de Jong-van den Berg LT, van den Berg PB, Peters PW, Haaijer-Ruskamp FM. A study of drug utilization in pregnancy in the light of known risks: is there room for improvement?. Int J Risk Saf Med. 1990;1(2):91-105. doi: 10.3233/JRS-1990-1201. PMID: 23511586.
Copy Download .nbib Format: NLM
Rational pharmacotherapy and clinical practice guidelines. Theories and perspectives on implementing pharmacotherapeutic treatment guidelines.

Pharmacy world & science : PWS

Fijn R, Brouwers JR, Timmer JW, de Jong-van den Berg LT.
PMID: 11103386
Pharm World Sci. 2000 Aug;22(4):152-8. doi: 10.1023/a:1008727528545.

Several theories behind implementing clinical guidelines have been described within the literature. At first sight, these may seem different. However, there are similarities and eventually they are rather complementary than mutually exclusive. This article integrates several theoretical views on...

Cite
Fijn R, Brouwers JR, Timmer JW, et al. Rational pharmacotherapy and clinical practice guidelines. Theories and perspectives on implementing pharmacotherapeutic treatment guidelines. Pharm World Sci. 2000;22(4):152-8doi: 10.1023/a:1008727528545.
Fijn, R., Brouwers, J. R., Timmer, J. W., & de Jong-van den Berg, L. T. (2000). Rational pharmacotherapy and clinical practice guidelines. Theories and perspectives on implementing pharmacotherapeutic treatment guidelines. Pharmacy world & science : PWS, 22(4), 152-8. https://doi.org/10.1023/a:1008727528545
Fijn, R, et al. "Rational pharmacotherapy and clinical practice guidelines. Theories and perspectives on implementing pharmacotherapeutic treatment guidelines." Pharmacy world & science : PWS vol. 22,4 (2000): 152-8. doi: https://doi.org/10.1023/a:1008727528545
Fijn R, Brouwers JR, Timmer JW, de Jong-van den Berg LT. Rational pharmacotherapy and clinical practice guidelines. Theories and perspectives on implementing pharmacotherapeutic treatment guidelines. Pharm World Sci. 2000 Aug;22(4):152-8. doi: 10.1023/a:1008727528545. PMID: 11103386.
Copy Download .nbib Format: NLM
Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy.

JMIR public health and surveillance

Dreyer NA, Blackburn SC, Mt-Isa S, Richardson JL, Thomas S, Laursen M, Zetstra-van der Woude P, Jamry-Dziurla A, Hliva V, Bourke A, de Jong-van den Berg L.
PMID: 27227140
JMIR Public Health Surveill. 2015 Dec 22;1(2):e22. doi: 10.2196/publichealth.4939. eCollection 2015.

BACKGROUND: Little is known about the effects of human fetal exposure when a new drug is authorized unless it was specifically developed for use in pregnancy. Since many factors may contribute to adverse fetal effects, having comprehensive information about...

Cite
Dreyer NA, Blackburn SC, Mt-Isa S, et al. Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy. JMIR Public Health Surveill. 2015;1(2):e22doi: 10.2196/publichealth.4939.
Dreyer, N. A., Blackburn, S. C., Mt-Isa, S., Richardson, J. L., Thomas, S., Laursen, M., Zetstra-van der Woude, P., Jamry-Dziurla, A., Hliva, V., Bourke, A., & de Jong-van den Berg, L. (2015). Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy. JMIR public health and surveillance, 1(2), e22. https://doi.org/10.2196/publichealth.4939
Dreyer, Nancy A, et al. "Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy." JMIR public health and surveillance vol. 1,2 (2015): e22. doi: https://doi.org/10.2196/publichealth.4939
Dreyer NA, Blackburn SC, Mt-Isa S, Richardson JL, Thomas S, Laursen M, Zetstra-van der Woude P, Jamry-Dziurla A, Hliva V, Bourke A, de Jong-van den Berg L. Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy. JMIR Public Health Surveill. 2015 Dec 22;1(2):e22. doi: 10.2196/publichealth.4939. eCollection 2015. PMID: 27227140; PMCID: PMC4869223.
Copy Download .nbib Format: NLM
The pharmaceutical industry and the lay press: the industry's point of view.

The International journal of risk & safety in medicine

van Trigt AM, de Jong-van den Berg LT, Willems J, Tromp TD, Haaijer-Ruskamp FM.
PMID: 23511668
Int J Risk Saf Med. 1995;7(1):1-15. doi: 10.3233/JRS-1995-7102.

The general public has a high degree of interest in information relating to health and illness. Family magazines and daily newspapers play an important role as sources of information about these subjects. Journalists writing about medicines in newspapers in...

Cite
van Trigt AM, de Jong-van den Berg LT, Willems J, et al. The pharmaceutical industry and the lay press: the industry's point of view. Int J Risk Saf Med. 1995;7(1):1-15doi: 10.3233/JRS-1995-7102.
van Trigt, A. M., de Jong-van den Berg, L. T., Willems, J., Tromp, T. D., & Haaijer-Ruskamp, F. M. (1995). The pharmaceutical industry and the lay press: the industry's point of view. The International journal of risk & safety in medicine, 7(1), 1-15. https://doi.org/10.3233/JRS-1995-7102
van Trigt, A M, et al. "The pharmaceutical industry and the lay press: the industry's point of view." The International journal of risk & safety in medicine vol. 7,1 (1995): 1-15. doi: https://doi.org/10.3233/JRS-1995-7102
van Trigt AM, de Jong-van den Berg LT, Willems J, Tromp TD, Haaijer-Ruskamp FM. The pharmaceutical industry and the lay press: the industry's point of view. Int J Risk Saf Med. 1995;7(1):1-15. doi: 10.3233/JRS-1995-7102. PMID: 23511668.
Copy Download .nbib Format: NLM
The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review.

Drugs - real world outcomes

de Jong J, Garne E, de Jong-van den Berg LT, Wang H.
PMID: 27398292
Drugs Real World Outcomes. 2016 May 24;3(2):131-143. doi: 10.1007/s40801-016-0078-1. eCollection 2016 Jun.

BACKGROUND: More information is needed about possible associations between the newer anti-epileptic drugs (AEDs) in the first trimester of pregnancy and specific congenital anomalies of the fetus.OBJECTIVES: We performed a literature review to find signals for potential associations between...

Cite
de Jong J, Garne E, de Jong-van den Berg LT, et al. The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review. Drugs Real World Outcomes. 2016;3(2):131-143doi: 10.1007/s40801-016-0078-1.
de Jong, J., Garne, E., de Jong-van den Berg, L. T., & Wang, H. (2016). The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review. Drugs - real world outcomes, 3(2), 131-143. https://doi.org/10.1007/s40801-016-0078-1
de Jong, Josta, et al. "The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review." Drugs - real world outcomes vol. 3,2 (2016): 131-143. doi: https://doi.org/10.1007/s40801-016-0078-1
de Jong J, Garne E, de Jong-van den Berg LT, Wang H. The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review. Drugs Real World Outcomes. 2016 May 24;3(2):131-143. doi: 10.1007/s40801-016-0078-1. eCollection 2016 Jun. PMID: 27398292; PMCID: PMC4914544.
Copy Download .nbib Format: NLM
A three-country comparison of psychotropic medication prevalence in youth.

Child and adolescent psychiatry and mental health

Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC.
PMID: 18817536
Child Adolesc Psychiatry Ment Health. 2008 Sep 25;2(1):26. doi: 10.1186/1753-2000-2-26.

BACKGROUND: The study aims to compare cross-national prevalence of psychotropic medication use in youth.METHODS: A population-based analysis of psychotropic medication use based on administrative claims data for the year 2000 was undertaken for insured enrollees from 3 countries in...

Cite
Zito JM, Safer DJ, de Jong-van den Berg LT, et al. A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health. 2008;2(1):26doi: 10.1186/1753-2000-2-26.
Zito, J. M., Safer, D. J., de Jong-van den Berg, L. T., Janhsen, K., Fegert, J. M., Gardner, J. F., Glaeske, G., & Valluri, S. C. (2008). A three-country comparison of psychotropic medication prevalence in youth. Child and adolescent psychiatry and mental health, 2(1), 26. https://doi.org/10.1186/1753-2000-2-26
Zito, Julie M, et al. "A three-country comparison of psychotropic medication prevalence in youth." Child and adolescent psychiatry and mental health vol. 2,1 (2008): 26. doi: https://doi.org/10.1186/1753-2000-2-26
Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC. A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health. 2008 Sep 25;2(1):26. doi: 10.1186/1753-2000-2-26. PMID: 18817536; PMCID: PMC2569908.
Copy Download .nbib Format: NLM
Ovulation-inducing drugs: a drug utilization and risk study in the Dutch population.

The International journal of risk & safety in medicine

de Jong-van den Berg LT, Cornel MC, van den Berg PB, Bortolussi AC, Twerda HM, Lappöhn RE, Wesseling H.
PMID: 23510871
Int J Risk Saf Med. 1992;3(2):99-111. doi: 10.3233/JRS-1992-3205.

This study describes the use of the ovulation stimulating drugs clomifene, human chorionic gonadotropin (hCG) and human menopausal gonadotropin (hMG) in a representative sample of a population of Dutch women in the child-bearing age group. Clomifene or hMG/hCG are...

Cite
de Jong-van den Berg LT, Cornel MC, van den Berg PB, et al. Ovulation-inducing drugs: a drug utilization and risk study in the Dutch population. Int J Risk Saf Med. 1992;3(2):99-111doi: 10.3233/JRS-1992-3205.
de Jong-van den Berg, L. T., Cornel, M. C., van den Berg, P. B., Bortolussi, A. C., Twerda, H. M., Lappöhn, R. E., & Wesseling, H. (1992). Ovulation-inducing drugs: a drug utilization and risk study in the Dutch population. The International journal of risk & safety in medicine, 3(2), 99-111. https://doi.org/10.3233/JRS-1992-3205
de Jong-van den Berg, L T, et al. "Ovulation-inducing drugs: a drug utilization and risk study in the Dutch population." The International journal of risk & safety in medicine vol. 3,2 (1992): 99-111. doi: https://doi.org/10.3233/JRS-1992-3205
de Jong-van den Berg LT, Cornel MC, van den Berg PB, Bortolussi AC, Twerda HM, Lappöhn RE, Wesseling H. Ovulation-inducing drugs: a drug utilization and risk study in the Dutch population. Int J Risk Saf Med. 1992;3(2):99-111. doi: 10.3233/JRS-1992-3205. PMID: 23510871.
Copy Download .nbib Format: NLM
Registration of drug use in a birth defect monitoring system: a priority worthy of emphasis!.

The International journal of risk & safety in medicine

de Vries CS, de Walle HE, Cornel MC, de Jong-van den Berg LT.
PMID: 23511175
Int J Risk Saf Med. 1993;4(1):27-33. doi: 10.3233/JRS-1993-4104.

This article examines sources of information on drug use during pregnancy in the northeastern part of The Netherlands, comparing data from a congenital anomalies registry and figures obtained from community pharmacy records for a drug utilization study. Physicians and...

Cite
de Vries CS, de Walle HE, Cornel MC, et al. Registration of drug use in a birth defect monitoring system: a priority worthy of emphasis!. Int J Risk Saf Med. 1993;4(1):27-33doi: 10.3233/JRS-1993-4104.
de Vries, C. S., de Walle, H. E., Cornel, M. C., & de Jong-van den Berg, L. T. (1993). Registration of drug use in a birth defect monitoring system: a priority worthy of emphasis!. The International journal of risk & safety in medicine, 4(1), 27-33. https://doi.org/10.3233/JRS-1993-4104
de Vries, C S, et al. "Registration of drug use in a birth defect monitoring system: a priority worthy of emphasis!." The International journal of risk & safety in medicine vol. 4,1 (1993): 27-33. doi: https://doi.org/10.3233/JRS-1993-4104
de Vries CS, de Walle HE, Cornel MC, de Jong-van den Berg LT. Registration of drug use in a birth defect monitoring system: a priority worthy of emphasis!. Int J Risk Saf Med. 1993;4(1):27-33. doi: 10.3233/JRS-1993-4104. PMID: 23511175.
Copy Download .nbib Format: NLM
An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy.

JMIR public health and surveillance

Richardson JL, Stephens S, Thomas SHL, Jamry-Dziurla A, de Jong-van den Berg L, Zetstra-van der Woude P, Laursen M, Hliva V, Mt-Isa S, Bourke A, Dreyer NA, Blackburn SC.
PMID: 27227148
JMIR Public Health Surveill. 2016 Mar 18;2(1):e13. doi: 10.2196/publichealth.5366. eCollection 2016.

BACKGROUND: Knowledge of the fetal effects of maternal medication use in pregnancy is often inadequate and current pregnancy pharmacovigilance (PV) surveillance methods have important limitations. Patient self-reporting may be able to mitigate some of these limitations, providing an adequately...

Cite
Richardson JL, Stephens S, Thomas SHL, et al. An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. JMIR Public Health Surveill. 2016;2(1):e13doi: 10.2196/publichealth.5366.
Richardson, J. L., Stephens, S., Thomas, S. H. L., Jamry-Dziurla, A., de Jong-van den Berg, L., Zetstra-van der Woude, P., Laursen, M., Hliva, V., Mt-Isa, S., Bourke, A., Dreyer, N. A., & Blackburn, S. C. (2016). An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. JMIR public health and surveillance, 2(1), e13. https://doi.org/10.2196/publichealth.5366
Richardson, Jonathan Luke, et al. "An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy." JMIR public health and surveillance vol. 2,1 (2016): e13. doi: https://doi.org/10.2196/publichealth.5366
Richardson JL, Stephens S, Thomas SHL, Jamry-Dziurla A, de Jong-van den Berg L, Zetstra-van der Woude P, Laursen M, Hliva V, Mt-Isa S, Bourke A, Dreyer NA, Blackburn SC. An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. JMIR Public Health Surveill. 2016 Mar 18;2(1):e13. doi: 10.2196/publichealth.5366. eCollection 2016. PMID: 27227148; PMCID: PMC4869218.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries